Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor-Positive Platinum-Resistant or -Refractory Recurrent Ovarian Cancer
Anthony Bonaventura, Rachel L O'Connell, Cristina Mapagu, Philip J Beale, Orla M McNally, Linda R Mileshkin, Peter T Grant, Alison M Hadley, Jeffery CH Goh, Katrin M Sjoquist, Julie Martyn, Anna DeFazio, James Scurry, Michael L Friedlander
International Journal of Gynecological Cancer | LIPPINCOTT WILLIAMS & WILKINS | Published : 2017
Awarded by Cancer Australia
Awarded by Priority-driven Collaborative Cancer Research
The study was funded by grants from Cancer Australia (grant 632740) and Priority-driven Collaborative Cancer Research (scheme 1063014). Anastrozole was provided by AstraZeneca.